RADIATION-THERAPY FOR PRIMARY SQUAMOUS-CELL CARCINOMA OF THE VAGINA - STANFORD-UNIVERSITY EXPERIENCE GYNECOLOGIC ONCOLOGY Spirtos, N. M., DOSHI, B. P., Kapp, D. S., Teng, N. 1989; 35 (1): 20-26

Abstract

A retrospective analysis of 38 patients with primary squamous cell carcinoma of the vagina seen at Stanford University Medical Center from 1958 to 1984 was undertaken. Patients were analyzed with regard to symptoms, stage, treatment techniques, survival, patterns of failure, and complications. Eighteen patients were classified as FIGO Stage I, 5 as Stage II, 10 as Stage III, and 5 as Stage IV. The 5-year disease-free survival was 94% in Stage I, 80% in Stage II, 50% in Stage III, and 0% in Stage IV. Five patients (13%) had eight major complications secondary to treatment. Only 2 of 23 patients with Stage I or Stage II disease developed a recurrence. There was a significant correlation between dose and response in patients treated with radiotherapy.

View details for Web of Science ID A1989AT54200004

View details for PubMedID 2792898